Date: Tuesday, June 14, 2016
Session Name: Poster Session D: Psychosocial and Treatment Adherence
Session Time: 6:00pm-7:00pm
Presentation Time: 6:00pm-7:00pm
Location: Halls C&D
- Psychosocial Factors Associated with Medication Adherence Based on Self Reports in Kidney Allograft Recipients: Baseline Findings from the PRIMA (ImPRoving Adherence to Immunosuppressive Therapy by Mobile Internet Application) Study.
- Are Living Kidney Donors Who Apply Via a Web-Based Screening Application as Likely to Be Evaluated and Donate as Compared to Phone Applicants?
Introduction: The efficacy of a mobile phone application in promoting medication adherence and education was investigated to evaluate its utility in assisting liver and kidney transplant patients in managing immunosuppression.
Methods: Patients completed 3 surveys peri-operatively; a Beliefs about Medicine Questionnaire (BMQ) was used to establish baseline predilections about compliance in the early post-operative period. Patients were also assessed using the Morisky Medication Adherence Scale (MMAS-8) and tested on their medication recall by writing down their immunosuppressive medications approximately 3-months post-operatively. Serum tacrolimus levels and rejection episodes were also denoted as a surrogate for medication adherence.
Results: Overall, our transplant patients had a negative view of medications (BMQ score > 47 = negative beliefs about medicine); BMQ scores between app users (n=21) and non-users (n=53); (52.4 v. 58.29; p = 0.09). Also, there was no difference in mean tacrolimus levels between app users and non-users; (9.5 ug/ml v. 9.52 ug/ml; p=NS). However, app users had a higher educational component score than app non users (2.66 v. 1.87; p= 0.005). Interestingly, app users demonstrated a tendency toward poorer adherence behavior; MMAS-8 (1.33 v. 0.5; p=0.0027). The application users had one rejection episode, while the non-users had three rejection episodes (p=NS).
Conclusion: Admittedly, the introduction of an app to assist in medication compliance requires further investigation, longer study periods, and a larger volume of patients to determine its usefulness in this cohort. However, in this pilot study app users seemed to gain an educational benefit as it relates to their ability to accurately document their immunosuppressive treatment. Moreover, perhaps app users gained the most benefit as they were more likely to have a non-compliant behavior in the context of a negative belief about their medication in their peri-operatively period.
CITATION INFORMATION: Zanetti Yabur A, Rizzo A, Graham J, Rocca J. Introducing a Mobile Phone Application to Transplant Patients to Encourage Medication Compliance and Education in This At-Risk Cohort. Am J Transplant. 2016;16 (suppl 3).
To cite this abstract in AMA style:Zanetti A, Rizzo A, Graham J, Rocca J. Introducing a Mobile Phone Application to Transplant Patients to Encourage Medication Compliance and Education in This At-Risk Cohort. [abstract]. Am J Transplant. 2016; 16 (suppl 3). http://atcmeetingabstracts.com/abstract/introducing-a-mobile-phone-application-to-transplant-patients-to-encourage-medication-compliance-and-education-in-this-at-risk-cohort/. Accessed November 19, 2017.
« Back to 2016 American Transplant Congress